FY 2002 Actual Obligations |
FY 2003 Current Estimate |
FY 2004 Request |
Increase or Decrease |
|
---|---|---|---|---|
Total Program Level
|
$43,867,000 |
$8,000,000 |
$11,500,000 |
+ $3,500,000 |
Budget Authority |
$43,867,000 |
$8,000,000 |
$11,500,000 |
+$3,500,000 |
President's Management Agenda |
+$3,500,000 |
+$3,500,000 |
Fiscal Year |
Program Level |
Budget Authority |
User Fee |
---|---|---|---|
2000 Actual Obligations |
$10,553,000 |
$10,553,000 |
$0 |
2001 Actual Obligations |
$33,207,000 |
$33,207,000 |
$0 |
2002 Actual Obligations |
$43,867,000 |
$43,867,000 |
$0 |
2003 Estimate |
$8,000,000 |
$8,000,000 |
$0 |
2004 Estimate |
$11,500,000 |
$11,500,000 |
$0 |
The FDA Buildings and Facilities appropriation provides funding for new construction and for needed repairs and improvements to existing facilities across the United States.
The construction of the Arkansas Regional Laboratory is a cornerstone of the FDA field laboratory consolidation plan. The completion of the ARL project will support the overall agency mission by ensuring that FDA-regulated products continue to comply with the Food, Drugs, and Cosmetic Act, as amended. The ARL provides analytical support in chemistry and microbiology for FDA’s southwest region. The completion of building 50 will provide a common administration building for the National Center for Toxicological Research and the Office of Regulatory Affairs at the Jefferson Laboratories in Jefferson, Arkansas.
FDA’s FY 2004 budget reflects the final completion of Phase III of the Arkansas Regional Laboratory. Phase III received $3 million in FY 2002.
The first two phases of construction for Building 50 completed exterior demolition, structural work, roofing repair, installation of an elevator, and installation of a new exterior brick facade. The interior architectural fit-out of the space has not been completed nor has the installation of mechanical and electrical infrastructure. The cost of completing the project is $3,500,000.
Base resources of $8,000,000 cover the costs of repairs and improvements to FDA facilities, owned and leased. Included are Maryland site components which are now located in approximately 40 buildings in 16 separate locations; plus five regional offices, 19 field District complexes including 19 administrative and 13 specialized laboratory facilities nationwide; more than 120 field resident posts, eight field criminal investigation offices, two distinct program laboratory complexes outside the Washington D.C. Metro area; and the NCTR complex in Jefferson, Arkansas. With all of these facilities combined, FDA maintains offices and staff in 49 of the 50 States, and in the District of Columbia and Puerto Rico.
For comparison purposes, industry components regulated by FDA spend between nine percent and 12 percent of the value of their physical plants on maintenance, alteration, and repair, while FDA's spends about two percent on laboratories and laboratory support facilities for the same purpose. This makes it more difficult for FDA scientists to keep pace with the technological advances that fuel incoming premarket applications. Planned repairs and improvement projects for FY 2004 are as follows:
ORA, Nationwide - Miscellaneous Repair and Improvement |
$2,000,000
|
CFSAN, Dauphin Island, AL -Miscellaneous Repair and Improvement |
350,000
|
CFSAN, College Park, MD - Miscellaneous Repair and Improvement |
350,000
|
CDER, St. Louis, MO - Laboratory fit-out costs |
250,000
|
CDER, Kensington, MD - Nicholson Lane Decommissioning |
100,000
|
CDER, Rockville, MD - Miscellaneous Repair and Improvement |
250,000
|
CBER, Bethesda, MD - Miscellaneous Repair and Improvement |
250,000
|
CDRH, Rockville, MD - Miscellaneous Repair and Improvement |
100,000
|
CVM, Laurel, MD – Mod II - Miscellaneous Repair and Improvement |
250,000
|
Mod I, Mod II, and BRF, Laurel, MD - Infrastructure Repairs and Improvement |
1,500,000
|
NCTR, Jefferson, AR -Fire alarm design bldgs 5D, 51, and 6 and install alarm in bldgs 53 and 62 |
230,000
|
NCTR, Jefferson, AR - Construction funds for renovation of bldg 51 |
1,500,000
|
NCTR, Jefferson, AR - Design and construction funds for pathology lab |
600,000
|
NCTR, Jefferson, AR - Miscellaneous Repair and Improvement |
270,000
|
TOTAL |
$8,000,000
|
As a part of FDA's plan to restructure its eighteen field laboratories, ARL is one of five multi-disciplined laboratories and will provide laboratory support for a seventeen statewide area and for the U.S-Mexican border stretching from Otay Mesa, California to Brownsville, Texas. The ARL provides analytical support in chemistry and microbiology. The ARL scientists are testing products regulated by the FDA to ensure compliance with the U.S. Food, Drug and Cosmetic Act, which will include products produced in the U.S. and imported.
A building dedication ceremony for Phases I & II, the laboratory portion, was held on February 17, 2000. ORA began occupying the laboratory facility in June 2000. The laboratory building is now fully operational.
The contract for construction of Phase I was awarded to Hensel Phelps Construction Company (HPCC) on February 27, 2001 and Phase II was awarded on November 29, 2001. The total project was approximately 70 percent complete as of July 31, 2002. Construction completion is projected by July 2003.
FDA Home Page | Search | A-Z Index | Site Map | Contact FDA
OC/OFM
Web page edited by sml
06/27/2003